Dai, Congxin
Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways. [electronic resource]
- International journal of cancer Oct 2013
- 1982-93 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 1097-0215
Standard No.: 10.1002/ijc.28199 doi
Subjects--Topical Terms: Animals Antineoplastic Agents, Alkylating--pharmacology Apoptosis--drug effects Caspase 3--metabolism Caspase 7--metabolism Caspase 9--metabolism Cathepsin B--biosynthesis Cell Cycle Checkpoints--drug effects Cell Line, Tumor Cell Proliferation--drug effects Cytochromes c--metabolism DNA Damage Dacarbazine--analogs & derivatives Drug Synergism Female Folic Acid Antagonists--pharmacology Histones--metabolism Leucovorin--pharmacology Matrix Metalloproteinase 2--biosynthesis Matrix Metalloproteinase 9--biosynthesis Mice Mice, Inbred NOD Mice, SCID Mitochondria--drug effects Neoplasm Invasiveness Neoplasm Transplantation Phosphorylation--drug effects Pituitary Neoplasms--drug therapy Poly (ADP-Ribose) Polymerase-1 Poly(ADP-ribose) Polymerases--metabolism Proto-Oncogene Proteins c-bcl-2--biosynthesis Pyrimethamine--pharmacology Rats Temozolomide Up-Regulation--drug effects Xenograft Model Antitumor Assays bcl-2-Associated X Protein--biosynthesis